摘要
目的:分析不同浓度盐酸罗哌卡因前锯肌平面阻滞(SAPB)在机器人辅助胸腔镜下肺切除术手术患者中的镇痛效果。方法:选取2021年12月至2022年10月青岛大学附属医院收治的100例肺癌患者为研究对象,按随机数字表法将患者分为A组、S1组、S2组、S3组,各25例。4组均行达芬奇机器人辅助胸腔镜下肺切除术治疗,A组行单纯全身麻醉,另外3组术中分别采用0.25%、0.375%、0.50%浓度盐酸罗哌卡因进行SAPB麻醉,比较4组患者术后疼痛程度、静脉自控镇痛(PCIA)使用状况及并发症发生状况。结果:与A组相比,S3组T2-3时静态VAS评分及T1-5时动态VAS评分降低(P 0.05)。S3组的镇痛泵药液用量低于A组、S1组、S2组(P < 0.05),补救镇痛次数低于A组、S1组(P < 0.05)。四组术后头晕头痛、恶心呕吐等不良反应发生率无明显差异。结论:0.5%的罗哌卡因用于前锯肌平面阻滞更有利于缓解机器人辅助胸外科(RATS)肺切除术后疼痛,延长镇痛持续时间,减少镇痛药物用量,适用于RATS肺切除手术后疼痛管理。
Objective: To analyze the analgesic effect of different concentrations of ropivacaine hydrochloride anterior serratus plane block (SAPB) in patients undergoing robot-assisted pulmonary resections abstract. Methods: A total of 100 patients with lung cancer admitted to the Affiliated Hospital of Qingdao University from December 2021 to October 2022 were selected as the study subjects. Ac-cording to the random number table method, the patients were divided into group A, group S1, group S2 and group S3, with 25 cases in each group. All 4 groups received robot-assisted thoraco-scopic pneumonectomy. Group A underwent simple general anesthesia. SAPB anesthesia was per-formed with 0.25%, 0.375% and 0.50% ropivacaine in the other three groups. Compared with group A, the static VAS score at T2-3 and the dynamic VAS score at T1-5 were decreased in group S3 (P 0.05). The dosage of analgesic pump in group S3 was lower than that in group A, group S1 and group S2 (P < 0.05), and the number of remedial analgesia was lower than that in group A and group S1 (P < 0.05). There was no significant difference in the incidence of adverse reactions, such as dizziness, headache, nausea and vomiting among the four groups. Results: 0.5% ropivacaine for serratus an-terior plane block is more conducive to relieving pain after robot-assisted thoracic surgery (RATS) pneumonectomy, prolonging the duration of analgesia, reducing the amount of analgesic drugs, and is suitable for pain management after RATS pneumonectomy.
出处
《临床医学进展》
2023年第4期5779-5784,共6页
Advances in Clinical Medicine